ArticleHealth and quality of life outcomes2021

Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus.

Evy Yunihastuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.